Last reviewed · How we verify
PATH-wSP
At a glance
| Generic name | PATH-wSP |
|---|---|
| Sponsor | PATH |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of wSp Vaccine in Young Children (PHASE2)
- Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers
- Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers (PHASE1, PHASE2)
- A Study of a Vaccine for Pneumonia in Adults and Toddlers in Kenya (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PATH-wSP CI brief — competitive landscape report
- PATH-wSP updates RSS · CI watch RSS
- PATH portfolio CI